← FDA DRUG APPROVALS

FDA ANDA · ANDA091657

TRANEXAMIC ACID

Sponsor: MYLAN INSTITUTIONAL

APPLICATION
ANDA091657
TYPE
ANDA
ORIGINAL APPROVAL
2011-11-03
LATEST ACTION
2022-06-23
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TRANEXAMIC ACIDPrescription
TRANEXAMIC ACID 100MG/ML · INJECTABLE · INJECTION

Approval history

2022-06-23Labeling · Supplement 10 · standardAP
2020-10-19Labeling · Supplement 9 · standardAP
2018-05-14Labeling · Supplement 6 · standardAP
2015-09-29Labeling · Supplement 2 · standardAP
2011-11-03UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →